When it comes to medical developments, it was an exciting year in the pursuit of what was once impossible. Here are some top picks that genuinely are changing the medical and tech landscape.
When words like "world-renowned" are used in the medical realm (especially by people selling something, like an unnecessary product or procedure), beware. And then prepare yourself with a healthy dose of skepticism.
The people at the FDA probably never thought that they would have to officially state that DIY gene editing should not be done. But, they were wrong. People have not only started making HIV gene therapies in their living rooms, but, when they start injecting themselves on FB live, the FDA had to step in.
Newly released guidelines from the U.S. Food and Drug Administration (FDA) suggest illegitimate, unproven stem cell uses might become a thing of the past.
In an effort to combat patient non-compliance with medications, the Food and Drug Administration approved the first pill with an ingestible tracking sensor. Will it be used for good or evil, or something in between?
Since 1990 when health claims on foods were first authorized, the FDA has never reversed a decision to allow one. But it's in the process of doing so now — the one that links soy protein to a reduced risk of heart disease.
The sheer number of baby products on the market can overwhelm any new parent. But the Food and Drug Administration is cracking down on one in particular: the sleep positioner. Officials consider it dangerous to the infant, as its use has been connected to 12 fatalities to date.
Warning letters by the United States Food and Drug Administration (FDA) can be interesting to read. A recent one, from the end of September, is more interesting than most. The facilities of Nashoba Brook Bakery, located in Concord, MA, were inspected by the FDA and a number of violations were found and documented. Actually, to be clear, Nashoba Brook Bakery was found to be - in one phrase - a hot mess.
It is Game On! for President Trump appointee Scott Gottlieb, the commissioner of the Food and Drug Administration. Things are definitely changing there, and at this point, it's a pretty good start.
Bacteria that are resistant to one, multiple or even all known antibiotics – commonly known as superbugs – are a leading concern in the medical and scientific communities. With traditional methods of combating infections not working alternative ways are required, starting with rethinking the instruments used in hospitals.
An ongoing FDA investigation into allegedly harmful homeopathic teething products revealed (surprise!) a heap of significant violations found at a second facility. Not only that, but the company's sheer sketchiness – like preventing investigators from taking photos – is enough to make you question what it's hiding.
Due to the opaque nature of the pharmaceutical industry’s disclosures, a study published in JAMA Internal Medicine sought to quantify a standard amount companies spent on the research and development of cancer drugs. Do these R&D costs justify such high prices and revenues?